These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11819967)

  • 41. Five-year data out on Viread.
    AIDS Patient Care STDS; 2006 Dec; 20(12):887-8. PubMed ID: 17219618
    [No Abstract]   [Full Text] [Related]  

  • 42. Side effects. FDA issues warning about d4T and ddI during pregnancy.
    TreatmentUpdate; 2001; 12(8):6-7. PubMed ID: 12132441
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatic steatosis and ddI, d4T use.
    Bernard EJ
    IAPAC Mon; 2006 Jul; 12(7):240-1. PubMed ID: 17096496
    [No Abstract]   [Full Text] [Related]  

  • 44. It's time to face the Zerit problem.
    Vergel N
    GMHC Treat Issues; 2003 Mar; 17(3):12. PubMed ID: 12728861
    [No Abstract]   [Full Text] [Related]  

  • 45. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 47. Fat wasting--AZT vs. d4T.
    TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501826
    [No Abstract]   [Full Text] [Related]  

  • 48. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 49. The case against Zerit.
    Huff B
    GMHC Treat Issues; 2002 Oct; 16(10):1-4. PubMed ID: 12458548
    [No Abstract]   [Full Text] [Related]  

  • 50. Unmet challenges in HIV therapy and potential of stampidine.
    Uckun FM
    Arzneimittelforschung; 2006 Feb; 56(2A):117-20. PubMed ID: 16570820
    [No Abstract]   [Full Text] [Related]  

  • 51. Once-daily therapies.
    Carey D
    J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
    [No Abstract]   [Full Text] [Related]  

  • 53. Delavirdine (Rescriptor).
    Res Initiat Treat Action; 2000 Mar; 6(1):20-1. PubMed ID: 11708180
    [No Abstract]   [Full Text] [Related]  

  • 54. Zalcitabine (Hivid).
    Res Initiat Treat Action; 2000 Mar; 6(1):10-1. PubMed ID: 11708175
    [No Abstract]   [Full Text] [Related]  

  • 55. [Stavudine: current information].
    Saimot AG
    Presse Med; 1997 Apr; 26(11):514-5. PubMed ID: 9137384
    [No Abstract]   [Full Text] [Related]  

  • 56. Proceedings of the 2nd European Stavudine Symposium. Cannes, France, 25 April 1998.
    Antivir Ther; 1998; 3 Suppl 4():1-77. PubMed ID: 10755851
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessing and enhancing compliance with antiretroviral therapy.
    Klaus BD; Grodesky MJ
    Nurse Pract; 1997 Apr; 22(4):211-2, 215, 219. PubMed ID: 9128888
    [No Abstract]   [Full Text] [Related]  

  • 58. NDA filed for stavudine.
    AIDS Patient Care; 1994 Jun; 8(3):164. PubMed ID: 11362139
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute neuromyopathy syndrome.
    McArthur J
    Hopkins HIV Rep; 2002 Jul; 14(4):5. PubMed ID: 12116982
    [No Abstract]   [Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors.
    Guaraldi G; Stentarelli C; Orlando G; Zona S; Carli F; Ballestri S; Lonardo A; Squillace N; Loria P
    J Acquir Immune Defic Syndr; 2010 Feb; 53(2):278; author reply 278-81. PubMed ID: 20104126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.